Alvotech (ALVO)
NASDAQ: ALVO · Real-Time Price · USD
3.960
-0.030 (-0.75%)
At close: Mar 2, 2026, 4:00 PM EST
3.700
-0.260 (-6.57%)
Pre-market: Mar 3, 2026, 8:26 AM EST
Alvotech Revenue
Alvotech had revenue of $113.86M in the quarter ending September 30, 2025, with 10.56% growth. This brings the company's revenue in the last twelve months to $573.35M, up 45.55% year-over-year. In the year 2024, Alvotech had annual revenue of $491.98M with 426.84% growth.
Revenue (ttm)
$573.35M
Revenue Growth
+45.55%
P/S Ratio
2.16
Revenue / Employee
$566,551
Employees
1,012
Market Cap
1.24B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 491.98M | 398.60M | 426.84% |
| Dec 31, 2023 | 93.38M | 8.37M | 9.84% |
| Dec 31, 2022 | 85.02M | 45.33M | 114.23% |
| Dec 31, 2021 | 39.68M | -29.77M | -42.86% |
| Dec 31, 2020 | 69.45M | -13.23M | -16.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Perrigo Company | 4.25B |
| Evotec SE | 887.40M |
| ANI Pharmaceuticals | 883.37M |
| Tilray Brands | 837.32M |
| Collegium Pharmaceutical | 780.57M |
| Pacira BioSciences | 726.41M |
| Amphastar Pharmaceuticals | 719.89M |
| Harrow | 272.30M |
ALVO News
- 19 days ago - Alvotech Announces Increase in Number of Own Shares - GlobeNewsWire
- 26 days ago - Alvotech Announces Positive Top-Line Results from Pivotal Pharmacokinetic Study for Proposed Biosimilar to Entyvio® - GlobeNewsWire
- 4 weeks ago - Alvotech enters supply and commercialization agreements for Canada and Australia & New Zealand covering multiple biosimilar candidates - GlobeNewsWire
- 5 weeks ago - Alvotech: Why FDA Delays Don't Break The Bull Case - Seeking Alpha
- 6 weeks ago - Bragar Eagel & Squire, P.C. Continues Investigations into Alvotech and Beyond Meat on Behalf of Stockholders and Encourages Investors to Contact the Firm - GlobeNewsWire
- 7 weeks ago - Correction: Transactions of Managers and Closely Associated Persons - GlobeNewsWire
- 7 weeks ago - Transactions of Managers and Closely Associated Persons - GlobeNewsWire
- 2 months ago - Alvotech Secures Term Loan Facility of USD 100 Million - GlobeNewsWire